1 Study Coverage 1.1 Anti-nuclear Antibody (ANA) Testing Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Introduction 1.2 Global Anti-nuclear Antibody (ANA) Testing Outlook 2017 VS 2022 VS 2028 1.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size for the Year 2017-2028 1.2.2 Global Anti-nuclear Antibody (ANA) Testing Market Size for the Year 2017-2028 1.3 Anti-nuclear Antibody (ANA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Anti-nuclear Antibody (ANA) Testing in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Anti-nuclear Antibody (ANA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Anti-nuclear Antibody (ANA) Testing Market Dynamics 1.4.1 Anti-nuclear Antibody (ANA) Testing Industry Trends 1.4.2 Anti-nuclear Antibody (ANA) Testing Market Drivers 1.4.3 Anti-nuclear Antibody (ANA) Testing Market Challenges 1.4.4 Anti-nuclear Antibody (ANA) Testing Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Anti-nuclear Antibody (ANA) Testing by Type 2.1 Anti-nuclear Antibody (ANA) Testing Market Segment by Type 2.1.1 Indirect Immunofluorescence 2.1.2 Enzyme-linked Immunosorbent Assay (ELISA) 2.1.3 Other 2.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017, 2022 & 2028) 2.3 Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2028) 2.4 United States Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017, 2022 & 2028) 2.5 United States Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2028) 3 Anti-nuclear Antibody (ANA) Testing by Application 3.1 Anti-nuclear Antibody (ANA) Testing Market Segment by Application 3.1.1 Hospital 3.1.2 Clinic 3.1.3 Other 3.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017, 2022 & 2028) 3.3 Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2028) 3.4 United States Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017, 2022 & 2028) 3.5 United States Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2028) 4 Global Anti-nuclear Antibody (ANA) Testing Competitor Landscape by Company 4.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Company 4.1.1 Top Global Anti-nuclear Antibody (ANA) Testing Companies Ranked by Revenue (2021) 4.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue by Player (2017-2022) 4.2 Global Anti-nuclear Antibody (ANA) Testing Concentration Ratio (CR) 4.2.1 Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Anti-nuclear Antibody (ANA) Testing in 2021 4.2.3 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Anti-nuclear Antibody (ANA) Testing Headquarters, Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Type 4.3.1 Global Anti-nuclear Antibody (ANA) Testing Headquarters and Area Served 4.3.2 Global Anti-nuclear Antibody (ANA) Testing Companies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Anti-nuclear Antibody (ANA) Testing Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Anti-nuclear Antibody (ANA) Testing Market Size by Company 4.5.1 Top Anti-nuclear Antibody (ANA) Testing Players in United States, Ranked by Revenue (2021) 4.5.2 United States Anti-nuclear Antibody (ANA) Testing Revenue by Players (2020, 2021 & 2022) 5 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region 5.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2028) 5.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2017-2022 5.2.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2017-2028 6.1.2 North America Anti-nuclear Antibody (ANA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2017-2028 6.3.2 Europe Anti-nuclear Antibody (ANA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2017-2028 6.4.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Abcam 7.1.1 Abcam Company Details 7.1.2 Abcam Business Overview 7.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction 7.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.1.5 Abcam Recent Development 7.2 Antibodies 7.2.1 Antibodies Company Details 7.2.2 Antibodies Business Overview 7.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction 7.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.2.5 Antibodies Recent Development 7.3 Bio-Rad Laboratories 7.3.1 Bio-Rad Laboratories Company Details 7.3.2 Bio-Rad Laboratories Business Overview 7.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction 7.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.3.5 Bio-Rad Laboratories Recent Development 7.4 Alere 7.4.1 Alere Company Details 7.4.2 Alere Business Overview 7.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction 7.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.4.5 Alere Recent Development 7.5 Erba Diagnostics 7.5.1 Erba Diagnostics Company Details 7.5.2 Erba Diagnostics Business Overview 7.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction 7.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.5.5 Erba Diagnostics Recent Development 7.6 MBL International 7.6.1 MBL International Company Details 7.6.2 MBL International Business Overview 7.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction 7.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.6.5 MBL International Recent Development 7.7 Merck 7.7.1 Merck Company Details 7.7.2 Merck Business Overview 7.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction 7.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.7.5 Merck Recent Development 7.8 Indur Services 7.8.1 Indur Services Company Details 7.8.2 Indur Services Business Overview 7.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction 7.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.8.5 Indur Services Recent Development 7.9 Trinity Biotech 7.9.1 Trinity Biotech Company Details 7.9.2 Trinity Biotech Business Overview 7.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction 7.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.9.5 Trinity Biotech Recent Development 7.10 Thermo Fisher Scientific 7.10.1 Thermo Fisher Scientific Company Details 7.10.2 Thermo Fisher Scientific Business Overview 7.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction 7.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.10.5 Thermo Fisher Scientific Recent Development 7.11 Zeus Scientific 7.11.1 Zeus Scientific Company Details 7.11.2 Zeus Scientific Business Overview 7.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction 7.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) 7.11.5 Zeus Scientific Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Anti-nuclear Antibody (ANA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Anti-nuclear Antibody (ANA) Testing Market Trends Table 3. Anti-nuclear Antibody (ANA) Testing Market Drivers Table 4. Anti-nuclear Antibody (ANA) Testing Market Challenges Table 5. Anti-nuclear Antibody (ANA) Testing Market Restraints Table 6. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Anti-nuclear Antibody (ANA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Anti-nuclear Antibody (ANA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Anti-nuclear Antibody (ANA) Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Anti-nuclear Antibody (ANA) Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Player, 2017-2022 Table 13. Global Anti-nuclear Antibody (ANA) Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Anti-nuclear Antibody (ANA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2021) Table 15. Top Players of Anti-nuclear Antibody (ANA) Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Anti-nuclear Antibody (ANA) Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Anti-nuclear Antibody (ANA) Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States Anti-nuclear Antibody (ANA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Anti-nuclear Antibody (ANA) Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Anti-nuclear Antibody (ANA) Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Anti-nuclear Antibody (ANA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Anti-nuclear Antibody (ANA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Anti-nuclear Antibody (ANA) Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Anti-nuclear Antibody (ANA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Anti-nuclear Antibody (ANA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Abcam Company Details Table 31. Abcam Business Overview Table 32. Abcam Anti-nuclear Antibody (ANA) Testing Product Table 33. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 34. Abcam Recent Development Table 35. Antibodies Company Details Table 36. Antibodies Business Overview Table 37. Antibodies Anti-nuclear Antibody (ANA) Testing Product Table 38. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 39. Antibodies Recent Development Table 40. Bio-Rad Laboratories Company Details Table 41. Bio-Rad Laboratories Business Overview Table 42. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product Table 43. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 44. Bio-Rad Laboratories Recent Development Table 45. Alere Company Details Table 46. Alere Business Overview Table 47. Alere Anti-nuclear Antibody (ANA) Testing Product Table 48. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 49. Alere Recent Development Table 50. Erba Diagnostics Company Details Table 51. Erba Diagnostics Business Overview Table 52. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product Table 53. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 54. Erba Diagnostics Recent Development Table 55. MBL International Company Details Table 56. MBL International Business Overview Table 57. MBL International Anti-nuclear Antibody (ANA) Testing Product Table 58. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 59. MBL International Recent Development Table 60. Merck Company Details Table 61. Merck Business Overview Table 62. Merck Anti-nuclear Antibody (ANA) Testing Product Table 63. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 64. Merck Recent Development Table 65. Indur Services Company Details Table 66. Indur Services Business Overview Table 67. Indur Services Anti-nuclear Antibody (ANA) Testing Product Table 68. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 69. Indur Services Recent Development Table 70. Trinity Biotech Company Details Table 71. Trinity Biotech Business Overview Table 72. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product Table 73. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 74. Trinity Biotech Recent Development Table 75. Thermo Fisher Scientific Company Details Table 76. Thermo Fisher Scientific Business Overview Table 77. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product Table 78. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 79. Thermo Fisher Scientific Recent Development Table 80. Zeus Scientific Company Details Table 81. Zeus Scientific Business Overview Table 82. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product Table 83. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) & (US$ Million) Table 84. Zeus Scientific Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Anti-nuclear Antibody (ANA) Testing Product Picture Figure 2. Global Anti-nuclear Antibody (ANA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Anti-nuclear Antibody (ANA) Testing Market Size 2017-2028 (US$ Million) Figure 4. United States Anti-nuclear Antibody (ANA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Anti-nuclear Antibody (ANA) Testing Market Size 2017-2028 (US$ Million) Figure 6. United States Anti-nuclear Antibody (ANA) Testing Market Share in Global 2017-2028 Figure 7. Anti-nuclear Antibody (ANA) Testing Report Years Considered Figure 8. Product Picture of Indirect Immunofluorescence Figure 9. Product Picture of Enzyme-linked Immunosorbent Assay (ELISA) Figure 10. Product Picture of Other Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type in 2022 & 2028 Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028) Figure 14. United States Anti-nuclear Antibody (ANA) Testing Market Share by Type in 2022 & 2028 Figure 15. United States Anti-nuclear Antibody (ANA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Anti-nuclear Antibody (ANA) Testing Market Share by Type (2017-2028) Figure 17. Product Picture of Hospital Figure 18. Product Picture of Clinic Figure 19. Product Picture of Other Figure 20. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application in 2022 & 2028 Figure 21. Global Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028) Figure 23. United States Anti-nuclear Antibody (ANA) Testing Market Share by Application in 2022 & 2028 Figure 24. United States Anti-nuclear Antibody (ANA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Anti-nuclear Antibody (ANA) Testing Market Share by Application (2017-2028) Figure 26. North America Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. U.A.E Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 55. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 57. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 58. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 59. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 60. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 61. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 62. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 64. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Abcam Antibodies Bio-Rad Laboratories Alere Erba Diagnostics MBL International Merck Indur Services Trinity Biotech Thermo Fisher Scientific Zeus Scientific